Did you know?
WebOct 3, 2024 · Tenaya Therapeutics, a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, today announced the hires of Leone Patterson, MBA, as Chief Financial and Business Officer and Matthew Pollman, MD, MS, as Senior Vice President, Clinical Development. … WebFeb 15, 2024 · The latest Tweets from Tenaya Therapeutics (@TenayaThera). Scaling new heights in the fight against heart disease. South San Francisco, CA
WebTenaya Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update. TN-201 IND Cleared in January; Plan to Begin Phase 1b … We’ve assembled a leadership team to guide our science and our mission to … We are equal opportunity employers and offer competitive salaries and benefits. … TN-201: MYBPC3 Gene Therapy Program for Genetic HCM. We are developing TN … Cellular Regeneration. Problem: Heart cells that are lost (e.g. due to heart attack) … Tenaya Therapeutics 171 Oyster Point Blvd., Suite 500 South San Francisco, … The Investor Relations website contains information about Tenaya Therapeutics, … Our Studies. TN-301 Phase 1 Clinical Trial: We are currently enrolling healthy … The Investor Relations website contains information about Tenaya Therapeutics, … [email protected]: Tenaya Therapeutics Top Competitors. Company Employees Revenue Top technologies; Mustang Bio. 102: $34.4 M: Poseida Therapeutics. 283: …
WebJan 10, 2024 · Company announces development candidate selection of its second gene therapy program, TN-401, targeting the leading genetic cause of arrhythmogenic right ventricular cardiomyopathy (gARVC) IND applications for TN-201 and TN-301 (previously named TYA-11631) expected to be submitted in the second WebJan 10, 2024 · Company announces development candidate selection of its second gene therapy program, TN-401, targeting the leading genetic cause of arrhythmogenic right …
WebMar 17, 2024 · RT @TenayaThera: Tenaya CEO Faraz Ali will attend Gene Therapies for Rare Disorders on 3/21 in Boston to share perspectives on the industry outlook, and participate in panel conversations with peers on the progress of rare gene therapies in 2024.
WebDec 31, 2024 · Strengthened Leadership Team with the Additions of Sunita Sethi as Senior Vice President of Regulatory Affairs and Naymisha Patel as Senior Vice President of … how to create hostnameWebTenaya’s mission is to discover, develop, and deliver therapies that address the underlying drivers of heart disease. We were founded by leading cardiovascular scientists from, and have established academic collaborations with, Gladstone Institutes and University of Texas Southwestern Medical Center, and have forged additional partnerships ... microsoft service manager and sotiWebGet Laura Lombardi's email address (l*****@gmail.com) and phone number at RocketReach. Get 5 free searches. how to create horrorWebJul 7, 2024 · GEO help: Mouse over screen elements for information. Deep learning detects cardiotoxicity in a high-content screen with induced pluripotent stem cell-derived cardiomyocytes. Drug-induced cardiotoxicity and hepatotoxicity are major causes of drug attrition. To decrease late-stage drug attrition, pharmaceutical and biotechnology … microsoft service customer supportWebMar 13, 2024 · Laura Robertson contact details: Email address: l***@tenayathera.com Phone number: (***) ***-**** Who is Laura Robertson? Laura Robertson is an Executive Medical Director at Tenaya Therapeutics based in South San Francisco, California. Previously, Laura was a Medical Director, Cardiovascular Clinical Research at … how to create hot iceWebNov 23, 2024 · SOUTH SAN FRANCISCO, Calif., Nov. 23, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that Tenaya management will … microsoft service level agreementsWebJan 31, 2024 · SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Tenaya Therapeutics, Inc. (NASDAQ:TNYA), a biotechnology company with a mission to … how to create hosting website